Section 24.36.01.010 - DEFINITIONS AND ABBREVIATIONSThe definitions set forth in Sections 54-1704 and 37-2701, Idaho Code, are applicable to these rules. In addition, the following terms have the meanings set forth below:
01.ACCME. Accreditation Council for Continuing Medical Education.02.ACPE. Accreditation Council for Pharmacy Education.03.ADS - Automated Dispensing and Storage. A mechanical system that performs operations or activities, other than compounding or administration, relative to the storage, packaging, dispensing, or distribution of drugs and that collects, controls, and maintains transaction information.04.Change of Ownership. A change of majority ownership or controlling interest of a drug outlet licensed or registered by the Board.05.CME. Continuing medical education.06.CPE. Continuing pharmacy education.07.CPE Monitor. An NABP service that allows pharmacists to electronically keep track of CPE credits from ACPE-accredited providers.08.DEA. United States Drug Enforcement Administration.09.DME Outlet. A registered outlet that may hold for sale at retail durable medical equipment (DME) and the following prescription drugs: pure oxygen for human application, nitrous oxide, sterile sodium chloride, and sterile water for injection.10.Drug Outlet. Drug outlets include, but are not limited to, sterile product pharmacies, remote dispensing pharmacies, facilities operating narcotic treatment programs, DME outlets, prescriber drug outlets, outsourcing facilities, nuclear pharmacies, cognitive service pharmacies, correctional facilities, offsite ADSs for non-emergency dispensing, reverse distributors, mobile pharmacies, and analytical or research laboratories.11.FDA. United States Food and Drug Administration.12.Flavoring Agent. An additive in food or drugs in the minimum quantity necessary.13.Floor Stock. Drugs or devices not labeled for a specific patient that are maintained at a nursing station or other department of an institutional facility, excluding the pharmacy, for the purpose of administering to patients of the facility.14.Hazardous Drug. Any drug listed as such by the National Institute for Occupational Safety and Health or any drug identified by at least one (1) of the following criteria: carcinogenicity; teratogenicity or developmental toxicity; reproductive toxicity in humans; organ toxicity at low doses in humans or animals; genotoxicity; or new drugs that mimic existing hazardous drugs in structure or toxicity.15.HIPAA. Health Insurance Portability and Accountability Act of 1996.16.NABP. National Association of Boards of Pharmacy.17.NDC. National Drug Code.18.Parenteral Admixture. The preparation and labeling of sterile products intended for administration by injection.19.Pharmaceutical Care Services. A broad range of services for patients performed independently or in collaboration with other health care professionals. Pharmaceutical care services are not limited to, but may include one (1) or more of the following:a. Diagnosing the patient's health status or condition;b. Reviewing or formulating a drug utilization plan;c. Monitoring and evaluating the patient's response to drug therapy;d. Ordering and interpreting laboratory tests and imaging;e. Performing drug product selection, substitution, medication administration, prescription adaptation, or refill authorization as provided in these rules; andf. Prescribing drugs and devices as provided in these rules.20.PDMP. Prescription Drug Monitoring Program.21.Prescriber. An individual currently licensed, registered, or otherwise authorized to prescribe and administer drugs in the course of professional practice.22.Purple Book. The list of licensed biological products with reference product exclusivity and biosimilarity or interchangeability evaluations published by the FDA under the Public Health Service Act.23.Readily Retrievable. Records are considered readily retrievable if they are able to be completely and legibly produced upon request within seventy-two (72) hours.24.Reconstitution. The process of adding a diluent to a powdered medication to prepare a solution or suspension, according to the product's labeling or the manufacturer's instructions.25.Restricted Drug Storage Area. The area of a drug outlet where prescription drugs are prepared, compounded, distributed, dispensed, or stored.26.Therapeutic Equivalent Drugs. Products assigned an "A" code by the FDA in the Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) and animal drug products published in the FDA Approved Animal Drug Products (Green Book).27.USP-NF. United State Pharmacopeia-National Formulary.Idaho Admin. Code r. 24.36.01.010
Effective July 1, 2024 (Temporary)